Sandra Cauwenberghs Selected Research

Sandra Cauwenberghs Research Topics

4	Thrombosis (Thrombus) 10/2007 - 02/2006
3	Neoplasms (Cancer) 12/2018 - 02/2011
2	Leukemia 01/2020 - 06/2011
1	Pathologic Neovascularization 01/2014
1	Necrosis 01/2013
1	Vascular Diseases (Vascular Disease) 05/2012
1	Hyperlipidemias (Hyperlipidemia) 05/2012
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2011
1	Inflammation (Inflammations) 06/2008
1	Thrombocytopenia (Thrombopenia) 02/2007

2	Imatinib Mesylate (Gleevec)FDA Link 01/2020 - 06/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014 - 02/2011
1	PF-06840003IBA 12/2018
1	KynurenineIBA 12/2018
1	LigandsIBA 12/2018
1	Blocking AntibodiesIBA 12/2018
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 12/2017
1	EnzymesIBA 12/2017
1	Tryptophan (L-Tryptophan)FDA Link 12/2017
1	Complement System Proteins (Complement)IBA 01/2013
1	CX3C Chemokine Receptor 1IBA 05/2012
1	Chemokine ReceptorsIBA 05/2012
1	Oxygen (Dioxygen)IBA 02/2011
1	Pharmaceutical PreparationsIBA 02/2011
1	SialyltransferasesIBA 06/2008
1	Hemostatics (Antihemorrhagics)IBA 10/2007
1	Thrombin FDA Link 02/2007
1	Purinergic Receptors (Receptors, Purine)IBA 06/2006
1	P-SelectinIBA 02/2006
1	CollagenIBA 02/2006
1	Adenosine Diphosphate (ADP)IBA 02/2006

3	Therapeutics 12/2018 - 02/2007
2	Drug Therapy (Chemotherapy) 02/2011 - 02/2007
1	Immunotherapy 12/2018
1	Platelet Transfusion (Blood Platelet Transfusions) 02/2007